Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Dipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Rome, Italy.
Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Rome, Italy.
Ultrasound Obstet Gynecol. 2021 Dec;58(6):916-925. doi: 10.1002/uog.23650.
Fusion imaging is an emerging technique that combines real-time ultrasound examination with images acquired previously using other modalities, such as computed tomography (CT), magnetic resonance imaging and positron emission tomography. The primary aim of this study was to evaluate the feasibility of fusion imaging in patients with suspicion of ovarian or peritoneal cancer. Secondary aims were: to compare the agreement of findings on fusion imaging, CT alone and ultrasound imaging alone with laparoscopic findings, in the assessment of extent of intra-abdominal disease; and to evaluate the time required for the fusion imaging technique.
Patients with clinical and/or radiographic suspicion of advanced ovarian or peritoneal cancer who were candidates for surgery were enrolled prospectively between December 2019 and September 2020. All patients underwent a CT scan and ultrasound and fusion imaging to evaluate the presence or absence of the following abdominal-cancer features according to the laparoscopy-based scoring model (predictive index value (PIV)): supracolic omental disease, visceral carcinomatosis on the liver, lesser omental carcinomatosis and/or visceral carcinomatosis on the lesser curvature of the stomach and/or spleen, involvement of the paracolic gutter(s) and/or anterior abdominal wall, involvement of the diaphragm and visceral carcinomatosis on the small and/or large bowel (regardless of rectosigmoid involvement). The feasibility of the fusion examination in these patients was evaluated. Agreement of each imaging method (ultrasound, CT and fusion imaging) with laparoscopy (considered as reference standard) was calculated using Cohen's kappa coefficient.
Fifty-two patients were enrolled into the study. Fusion imaging was feasible in 51 (98%) of these patients (in one patient, it was not possible for technical reasons). Two patients were excluded because laparoscopy was not performed, leaving 49 women in the final analysis. Kappa values for CT, ultrasound and fusion imaging, using laparoscopy as the reference standard, in assessing the PIV parameters were, respectively: 0.781, 0.845 and 0.896 for the great omentum; 0.329, 0.608 and 0.847 for the liver surface; 0.472, 0.549 and 0.756 for the lesser omentum and/or stomach and/or spleen; 0.385, 0.588 and 0.795 for the paracolic gutter(s) and/or anterior abdominal wall; 0.385, 0.497 and 0.657 for the diaphragm; and 0.336, 0.410 and 0.469 for the bowel. The median time needed to perform the fusion examination was 20 (range, 10-40) min.
Fusion of CT images and real-time ultrasound imaging is feasible in patients with suspicion of ovarian or peritoneal cancer and improves the agreement with surgical findings when compared with ultrasound or CT scan alone. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.
融合成像技术是一种新兴技术,它将实时超声检查与之前使用其他方式(如计算机断层扫描(CT)、磁共振成像和正电子发射断层扫描)获得的图像结合在一起。本研究的主要目的是评估融合成像在疑似卵巢或腹膜癌患者中的可行性。次要目的是:比较融合成像、单独 CT 和单独超声成像在评估腹腔内疾病范围方面与腹腔镜检查结果的一致性;并评估融合成像技术所需的时间。
2019 年 12 月至 2020 年 9 月,前瞻性纳入有临床和/或影像学怀疑患有晚期卵巢或腹膜癌且适合手术的患者。所有患者均行 CT 扫描和超声及融合成像检查,以根据腹腔镜检查评分模型(预测指数值(PIV))评估以下腹部癌特征的存在或不存在:大网膜上疾病、肝脏内脏癌转移、小网膜癌转移和/或胃小弯和/或脾内脏癌转移、结肠旁沟(s)和/或前腹壁受累、膈肌受累和小/大肠内脏癌转移(无论直肠乙状结肠是否受累)。评估这些患者融合检查的可行性。使用 Cohen's kappa 系数计算每种成像方法(超声、CT 和融合成像)与腹腔镜检查(作为参考标准)的一致性。
共有 52 名患者入组研究。51 名(98%)患者的融合成像可行(由于技术原因,1 名患者无法进行)。两名患者因未行腹腔镜检查而被排除,最终有 49 名女性进行了最终分析。使用腹腔镜检查作为参考标准,CT、超声和融合成像评估 PIV 参数的 Kappa 值分别为:大网膜为 0.781、0.845 和 0.896;肝脏表面为 0.329、0.608 和 0.847;小网膜和/或胃和/或脾为 0.472、0.549 和 0.756;结肠旁沟(s)和/或前腹壁为 0.385、0.588 和 0.795;膈肌为 0.385、0.497 和 0.657;肠为 0.336、0.410 和 0.469。进行融合检查的中位时间为 20(范围 10-40)min。
在疑似卵巢或腹膜癌的患者中,CT 图像与实时超声成像融合是可行的,与单独使用超声或 CT 扫描相比,它可以提高与手术结果的一致性。 © 2021 年国际妇产科超声学会。